Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody

Elife. 2018 Oct 18:7:e38970. doi: 10.7554/eLife.38970.

Abstract

Dengue fever is caused by four different serotypes of dengue virus (DENV) which is the leading cause of worldwide arboviral diseases in humans. Virus-like particles (VLPs) containing flavivirus prM/E proteins have been demonstrated to be a potential vaccine candidate; however, the structure of dengue VLP is poorly understood. Herein VLP derived from DENV serotype-2 were engineered becoming highly matured (mD2VLP) and showed variable size distribution with diameter of ~31 nm forming the major population under cryo-electron microscopy examination. Furthermore, mD2VLP particles of 31 nm diameter possess a T = 1 icosahedral symmetry with a groove located within the E-protein dimers near the 2-fold vertices that exposed highly overlapping, cryptic neutralizing epitopes. Mice vaccinated with mD2VLP generated higher cross-reactive (CR) neutralization antibodies (NtAbs) and were fully protected against all 4 serotypes of DENV. Our results highlight the potential of 'epitope-resurfaced' mature-form D2VLPs in inducing quaternary structure-recognizing broad CR NtAbs to guide future dengue vaccine design.

Keywords: broad antibody response; cryoEM; dengue; infectious disease; microbiology; molecular biophysics; mouse; structural biology; vaccine; virus; virus-like particle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Neutralizing / immunology*
  • Dengue Vaccines / immunology*
  • Dengue Virus / classification
  • Dengue Virus / immunology*
  • Dengue Virus / ultrastructure
  • Epitopes / chemistry
  • Epitopes / immunology*
  • Female
  • Immunization
  • Mice, Inbred BALB C
  • Serotyping
  • Solvents
  • Survival Analysis
  • Vaccines, Virus-Like Particle / immunology*
  • Vaccines, Virus-Like Particle / ultrastructure
  • Viral Envelope Proteins / chemistry
  • Viral Envelope Proteins / metabolism
  • Virion / metabolism
  • Virion / ultrastructure

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Dengue Vaccines
  • Epitopes
  • Solvents
  • Vaccines, Virus-Like Particle
  • Viral Envelope Proteins
  • prM protein, Flavivirus

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.